NCT02651883View on ClinicalTrials.gov

Effect of Human Papillomavirus Self-Collection on Cervical Cancer Screening in High Risk Women: My Body, My Test 3

NACompletedINTERVENTIONAL
Enrollment

665

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

April 10, 2020

Study Completion Date

April 10, 2020

Conditions
Cervical CancerUterine Cervical NeoplasmsHuman Papillomavirus
Interventions
BEHAVIORAL

Screening invitation (with education)

The participant will be provided with brief education about the importance and effectiveness of cervical cancer screening, and invited to schedule an appointment for a free in-clinic screening

BEHAVIORAL

Self-collection for HPV testing

Participant is provided with a kit to take a self-collected sample at home and return it by mail for HPV testing. Results are provided to participant by phone.

Trial Locations (1)

27599

University of North Carolina Gillings School of Public Health, Chapel Hill

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

UNC Lineberger Comprehensive Cancer Center

OTHER

NCT02651883 - Effect of Human Papillomavirus Self-Collection on Cervical Cancer Screening in High Risk Women: My Body, My Test 3 | Biotech Hunter | Biotech Hunter